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Platelets are well recognised as having a critical role in
haemostasis, the prevention of bleeding after injury, as well
as in the maintenance of the vascular system. In addition,
they have a major role in pathological conditions such as
thrombosis including cardiac infarction and stroke.
Although the normal blood platelet count lies between
150,000 and 350,000 platelets/ll, only a small part of these
(\10,000 platelets/ll) are actually necessary to prevent
bleeding normally, although severe injuries or major surgery
may consume more. This suggests that the large numbers of
platelets in the circulation have other, additional functions.
In evolution, platelets first appeared with the evolution of
marsupials and mammals. In earlier vertebrates, such as
reptiles and birds, the nucleated thrombocyte covers platelet
functions, whereas even further back the haemocyte includes
these functions as well as oxygen transport and immuno-
logical defence. Evolution from nucleated cells to platelets
has involved separation in functions from leukocytes and
erythrocytes, specialising in immunology and oxygen
transport, respectively. However, there is increasing evi-
dence that platelets carry other residual functions from their
common origin. Detailed analysis of receptors expressed by
platelets has revealed a wide range of newly discovered
molecules including several that are important in
immunology, particularly innate immunity. In addition, both
in patients and animal models, there is considerable evidence
that thrombocytopenia contributes to the severity of diseases
caused by pathogens, also supporting a role for platelets in
immune defence against these organisms. Although some
authors have argued for an important role for reactive oxygen
species in platelet defenses against pathogens, others have
provided evidence for a strong anti-pathogen effect due to
the major participation of the activated platelet in thrombin
generation [1].
In the series of papers forming this multi-author review,
the authors examine several aspects of platelet function
supporting the body’s defence against different categories of
pathogens. Semple and Freedman [2] review the evidence for
the overall role of platelets in innate immunity. Not only do
platelets carry critical receptors for the recognition of viru-
ses, bacteria and parasites, but there is increasing evidence
that they do indeed have important roles in defence against
these pathogens. In addition, platelets interact with many of
the major elements of the immune system, including
monocytes, dendritic cells and T-lymphocytes and in their
storage granules also contain a wide variety of immunolog-
ically active substances such as cytokines, chemokines, and
related defensins. In addition, they have themselves che-
mokine receptors, allowing their activation by chemokines
released from other platelets or immune cells [3]. CD154
(CD40L) is an important platelet component released on
activation that influences the adaptive immune system and
interactions with lymphocytes. Recent studies utilizing
CD154 knockout mice extend the role of platelet-derived
CD154 to the modulation of adaptive immune response by
enhancing antigen presentation, improving CD8? T cell
responses, and playing a critical function in T-dependent
humoral immunity under physiological conditions [4].
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Platelets and bacteria
Bacteria are among the many pathogens that interact with
platelets, both influenced by platelets and also affecting
platelets. Kerrigan and Cox [5] review platelet–bacterial
interactions and their role in various diseases, particularly
those of the cardiovascular system. Several studies have
shown that proteins secreted by or expressed on the surface
of specific bacteria can bind to platelets and in some cases
activate them. A wide range of different activities have
been shown, and it seems likely that interactions such as
these have a critical role in bacterial growth and aggression
within the cardiovascular system, such as in colonisation
and destruction of heart valves. It was suggested many
years ago that the early decrease in cardiovascular diseases,
observed in the USA from the 1950s on, and long before
any decrease in smoking, coincided with the onset of
advanced dental hygiene and the systematic removal of
dental plaque—a major source of bacteria—by trained
hygienists. This link between dental hygiene and circula-
tory infections has been strengthened by further research,
but gum disease remains seriously underestimated as a
preventable cause of cardiovascular disease. In some cases
bacteria seem able to subvert platelet responses for their
own ends. Platelets activated by bacteria can in turn acti-
vate endothelial cells and thus exacerbate sepsis.
Yeaman describes the role of platelets in defence against
bacteria and the mechanisms they use to achieve this [6].
As well as using innate immunity mechanisms, platelets
secrete a large number of granule components that affect
bacterial viability. A classic example is the chemokine
family member PF4, a strongly basic protein that binds
tightly to negatively charged bacteria and induces strong
immunological responses. The immunological response to
PF4/heparin complexes seen in heparin-induced thrombo-
cytopenia may be an unfortunate consequence of this anti-
bacteria mechanism. Additional platelet anti-bacterial
peptides are derived from other chemokine family mem-
bers by proteolysis and are mainly highly negatively
charged molecules. While a number of molecules released
from activated platelets have toxic effects on bacteria,
activated platelets themselves also affect bacteria by a
contact mechanism that may involve internalisation.
Among the molecules released from activated platelets are
defensins and other microbiocidal peptides. These include
the kinocidins, members of the chemokine family, such as
platelet factor 4 (PF4, CXCL4) and related structures, that
have bacteriocidal characteristics. Other molecules syn-
thesised by activated platelets are hydrogen peroxide and
reactive oxygen species, also toxic for bacteria. However,
some authors consider that these are minor mechanisms
and that the role of platelets in formation of thrombin has a
far greater effect on bacteria by generating a strong
bactericidal complex in proximity to activated platelet
membranes [7].
Platelet–neutrophil extracellular traps are another way in
which platelets contribute to anti-bacterial activity by
assisting neutrophils to lyse distributing DNA in a ‘‘spi-
der’s web’’ that entangles and sticks to bacteria [8].
Platelets and viruses
Viruses form another important pathogen class. Thrombo-
cytopenia commonly accompanies virus infections that
indeed may lead to idiopathic thrombasthenia purpura
(ITP) by mechanisms that, as the name suggests, remain
obscure. It has proved difficult to demonstrate a direct
connection, but research in this area is making progress.
Flaujac et al. [9] review the relationship between platelets
and viruses, dealing particularly with HIV where interac-
tions with platelets can have serious consequences for
public health. Increasing evidence points to platelets
playing an important role in anti-viral defence by poorly
understood mechanisms. As noted above, platelets are
equipped with many of the receptors and immunologically
active systems that are critical in immune cells proper. That
these also have important functions in platelets is therefore
hardly surprising. It should also be noted that severe
thrombocytopenia affects many health characteristics other
than simply haemostasis.
Recently, there has been increased interest in the role of
platelets in dengue, a severe tropical and subtropical viral
disease transmitted via a mosquito vector, and with climate
warming also more and more a threat to temperate regions.
Several papers have provided evidence for dengue virus
interactions with platelets, implying that dengue might also
be transmittable by platelet transfusions and leaving open
the question whether platelets can and do kill dengue virus
as part of the host defence [10].
Platelets and parasites
Throughout most of our evolution humans have been
exposed to high parasite loads, and these diseases still
remain major causes of mortality in the developing world.
Defences against parasites are still poorly understood,
although considerable advances have been made over the
last few decades. The major parasitic disease affecting
humans is malaria, and, despite advances in treatment,
between 1 and 3 million people die each year from it, many
of them children. One of the most virulent forms is cerebral
malaria, which has a poor prognosis. Thus, any advances in
understanding its basic pathology may be useful in devis-
ing better treatment methods. As part of this multi-author
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review, Cox and McConkey describe the role of platelets in
the pathogenesis of cerebral malaria [11].
In a recent important study, purified human platelets
have been shown to kill Plasmodium falciparum parasites
cultured in red blood cells [12]. Platelet inhibition by
aspirin and other platelet inhibitors blocked the lethal effect
human platelets exert on P. falciparum parasites. These
results indicate a protective function for platelets in the
early stages of erythrocytic infection distinct from their
role in cerebral malaria where they assist infected red blood
cells to bind within the cerebral vasculature.
However, platelets may well play a role in defense
against other parasites, although this has been poorly
studied. Some examples are briefly mentioned. In Lyme
disease caused by Borrelia burgdorferi, the platelet count
drops, implying a defensive role. The major platelet inte-
grin aIIbb3 is the main receptor for the spirochete [13].
Platelets have also been shown to be capable of killing
trypanosomes, though less efficiently than macrophages or
neutrophils [14].
Evidence has been obtained for a role for platelets in
innate defence against Schistosoma mansoni infections in
mice. In replicate experiments, worm burdens were signifi-
cantly increased in mice thrombocytopenic at the time of
infection compared with untreated mice. Induction of
thrombocytopenia 4 days after infection had no effect on
worm count. Platelets from non-immune mice adhere to and
kill mechanically transformed schistosomula in vitro.
Platelets may thus provide an innate defence against schis-
tosome infection, and the thrombocytopenia that occurs
during schistosome infections may be a strategy that helps
secondary parasites evade this type of host defence or could
reflect platelet losses during the defence reaction [15].
There is also evidence that platelets are involved in
patients infected with Echinococcus granulosus. The con-
centrations of b-thromboglobulin and platelet factor 4 in
infected patients were elevated compared with controls,
indicating that platelets had been activated [16].
In many of these parasitic diseases, it has been sug-
gested that the platelet IgE receptor has an important role.
Flow cytometry analysis showed that, like monocytes and
eosinophils, about 10–20% of platelets in normal individ-
uals are IgE-positive and that this increases to up to 50% in
patients with parasitic diseases, leading to increased levels
of circulating IgE, particularly in filariasis [17]. Binding of
IgE was reduced by anti-IgE receptor antibodies, and FceRI
was later shown to be present on platelets with about 800–
1,000 FceRI molecules per platelet [17] (1). Parasite-spe-
cific IgE binding to platelets followed by platelet activation
when these are cross-linked by binding to the parasites is
thought to be the major mechanism involved. As a result,
platelets produce oxygen metabolites and release granule
contents toxic for the parasite.
Platelets, parasites and allergies
Before the industrial era, all mammals were ‘normally’
infected with helminth parasites from shortly after birth
until adulthood. Only since the nineteenth century have
people living in developed countries organised sophisti-
cated water purification (chlorination) and sewage disposal
systems that have allowed them to escape helminth infec-
tion. Allergies are present at high levels in these human
populations as they are absent in populations still regularly
exposed to helminths. In addition, populations with ende-
mic helminth infections show little allergic pathology that
could be connected to the acquisition or elimination of
helminth parasites. It has therefore been suggested that
endemic helminth infections activate the Th2 system,
particularly at mucosal surfaces, to provide a different level
of immunological homeostasis than occurs at present in
developed societies. Under these conditions, mast cells,
eosinophils and IgE rarely participate in allergic reactions,
although they obviously participate in the control of hel-
minth infections. Allergic reactions can thus be considered
to be a pathologic consequence of the change in this
homeostatic mechanism and have no protective conse-
quences for the individual [18]. The realization that this
reciprocal relationship exists may open new approaches to
prevention of allergic disorders, which are becoming an
increasingly major problem in developed countries.
Some recent studies suggest that platelets may play an
important role in allergic inflammation through the high
affinity IgE receptor (FceRI), the low affinity IgE receptor
(FceRII/CD23) and the low affinity IgG receptor (FccRIIA/
CD32) expressed on the cell surface. Human platelets
released serotonin and the chemokine RANTES (regulated
upon activation, normal T expressed and presumably
secreted), induced via FceRI, but the biological implication
of human platelets in type I allergy is not yet clear. The
levels of RANTES released from platelets from allergic
patients and healthy individuals stimulated with monoclo-
nal antibody (Ab) to human FceRI a-chain or human
myeloma IgE and anti-human IgE Ab were compared. The
level of RANTES released from platelets of allergic
patients stimulated with human IgE and anti-human IgE
was significantly higher than that of healthy individuals.
While the surface expression levels of FceRI on the
platelets from allergic patients and healthy individuals
were not significantly different, the platelets from allergic
patients were more activated by the IgE–FceRI pathway
than those from healthy controls, suggesting a novel and
important role for human platelets in perpetuating allergic
inflammation through IgE and the FceRI [19].
Other studies indicated that both the presence of func-
tional, intact platelets and the release of inflammatory
mediators from platelets are crucial events for a sustained
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allergic inflammatory response. Recently, platelets were
shown to be critical for leukocyte recruitment in chronic
skin inflammation in a mouse model of chronic contact
dermatitis. Using platelet depletion and restitution in an
IgE-mediated intermediate hypersensitivity reaction in
skin, the effect of mediators released from activated
platelets on leukocyte recruitment was investigated [20].
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